POLE mutant ECs usually present with early lesions, high tumor grade, but showed a better prognosis, which is closely associated with the immune response, which warrants further novel immunotherapeutic explorations for POLE mutant EC (9, 10). The gene discussed is POLE; the disease is neoplasm.